AR099353A1 - Composiciones de triglicéridos y usos de las mismas - Google Patents
Composiciones de triglicéridos y usos de las mismasInfo
- Publication number
- AR099353A1 AR099353A1 ARP140104294A ARP140104294A AR099353A1 AR 099353 A1 AR099353 A1 AR 099353A1 AR P140104294 A ARP140104294 A AR P140104294A AR P140104294 A ARP140104294 A AR P140104294A AR 099353 A1 AR099353 A1 AR 099353A1
- Authority
- AR
- Argentina
- Prior art keywords
- solid composition
- solid
- group
- triglycerides
- acids
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 239000008247 solid mixture Substances 0.000 abstract 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 3
- 150000004665 fatty acids Chemical class 0.000 abstract 3
- 239000007787 solid Substances 0.000 abstract 3
- 150000003626 triacylglycerols Chemical class 0.000 abstract 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 150000007513 acids Chemical class 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 2
- 239000000194 fatty acid Substances 0.000 abstract 2
- 229930195729 fatty acid Natural products 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 abstract 1
- 229910052681 coesite Inorganic materials 0.000 abstract 1
- 229910052593 corundum Inorganic materials 0.000 abstract 1
- 229910052906 cristobalite Inorganic materials 0.000 abstract 1
- ZSDBFLMJVAGKOU-UHFFFAOYSA-N glycerol phenylbutyrate Chemical compound C=1C=CC=CC=1CCCC(=O)OCC(OC(=O)CCCC=1C=CC=CC=1)COC(=O)CCCC1=CC=CC=C1 ZSDBFLMJVAGKOU-UHFFFAOYSA-N 0.000 abstract 1
- 229960002815 glycerol phenylbutyrate Drugs 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 230000000750 progressive effect Effects 0.000 abstract 1
- 239000000377 silicon dioxide Substances 0.000 abstract 1
- 235000012239 silicon dioxide Nutrition 0.000 abstract 1
- 229910052682 stishovite Inorganic materials 0.000 abstract 1
- 229910052905 tridymite Inorganic materials 0.000 abstract 1
- 229910001845 yogo sapphire Inorganic materials 0.000 abstract 1
- 239000010457 zeolite Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Botany (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Fats And Perfumes (AREA)
- Fodder In General (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361904369P | 2013-11-14 | 2013-11-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR099353A1 true AR099353A1 (es) | 2016-07-20 |
Family
ID=53058066
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP140104294A AR099353A1 (es) | 2013-11-14 | 2014-11-14 | Composiciones de triglicéridos y usos de las mismas |
| ARP230102641A AR130666A2 (es) | 2013-11-14 | 2023-10-03 | Composición farmacéutica de aceite de triheptanoina y composición sólida |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP230102641A AR130666A2 (es) | 2013-11-14 | 2023-10-03 | Composición farmacéutica de aceite de triheptanoina y composición sólida |
Country Status (18)
| Country | Link |
|---|---|
| US (6) | US20160243071A1 (https=) |
| EP (2) | EP3782610A1 (https=) |
| JP (4) | JP2017501972A (https=) |
| KR (1) | KR102291310B1 (https=) |
| CN (2) | CN105764497A (https=) |
| AR (2) | AR099353A1 (https=) |
| AU (1) | AU2014348470B2 (https=) |
| CA (2) | CA2929688C (https=) |
| CL (1) | CL2016001130A1 (https=) |
| ES (1) | ES2833294T3 (https=) |
| IL (1) | IL245588B (https=) |
| MX (2) | MX383005B (https=) |
| MY (1) | MY177028A (https=) |
| PE (1) | PE20161024A1 (https=) |
| PH (1) | PH12016500821A1 (https=) |
| RU (1) | RU2016123169A (https=) |
| TW (1) | TWI640327B (https=) |
| WO (1) | WO2015073816A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105764497A (zh) * | 2013-11-14 | 2016-07-13 | 奥特吉尼克斯制药公司 | 三酸甘油酯的固体组合物及其用途 |
| US20190076383A1 (en) * | 2017-09-08 | 2019-03-14 | Horizon Therapeutics, Llc | Methods for treating urea cycle disorders |
| CA3110724A1 (en) | 2018-08-27 | 2020-03-05 | Exerkine Corporation | Method for treating lysosomal storage disease |
| US11583542B2 (en) | 2019-12-16 | 2023-02-21 | Amylyx Pharmaceuticals, Inc. | Compositions of bile acids and phenylbutyrate compounds |
| CN113476408A (zh) * | 2021-07-23 | 2021-10-08 | 兆科药业（广州）有限公司 | 一种苯丁酸甘油酯颗粒剂及其制备方法与应用 |
Family Cites Families (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3337596A (en) | 1965-02-18 | 1967-08-22 | Procter & Gamble | Synthesis of mixed glycerides |
| JPS5215834A (en) | 1975-07-12 | 1977-02-05 | Ajinomoto Kk | Method of producing food composition |
| US4753963A (en) | 1985-09-26 | 1988-06-28 | The Procter & Gamble Company | Nutritional fat suitable for enteral and parenteral products |
| JPH07102106B2 (ja) | 1987-06-10 | 1995-11-08 | 日清製粉株式会社 | 経口，経管栄養食の製造法 |
| KR100318295B1 (ko) | 1989-07-05 | 2002-11-16 | 가부시키가이샤 저펜에너지 | 냉각윤활제 |
| EP0421581A1 (en) | 1989-10-03 | 1991-04-10 | Warner-Lambert Company | Chewable spray dried spheroidal microcapsules and wax coated microcapsules and methods for preparing same |
| JPH0692848A (ja) | 1992-09-11 | 1994-04-05 | Sagami Chem Res Center | 糖尿病治療用乳剤 |
| JPH06145688A (ja) | 1992-11-10 | 1994-05-27 | Nippon San Sekiyu Kk | 冷凍機用潤滑油組成物 |
| JP2800610B2 (ja) * | 1992-12-15 | 1998-09-21 | 不二製油株式会社 | 水中油型乳化物の製造法 |
| JP3522843B2 (ja) * | 1994-07-29 | 2004-04-26 | 昭和産業株式会社 | リポ製剤 |
| US5746933A (en) | 1994-11-07 | 1998-05-05 | Nippon Oil Co., Ltd. | Lubricating oil and composition for refrigerating machine, and refrigerating machine |
| DE69612755T2 (de) * | 1995-02-07 | 2001-08-23 | Brusilow Enterprises, Llc | Triglyceride und ethylester von phenylalkansäuren und phenylalkensäuren zur behandlung verschiedener erkrankungen |
| US5698210A (en) | 1995-03-17 | 1997-12-16 | Lee County Mosquito Control District | Controlled delivery compositions and processes for treating organisms in a column of water or on land |
| JPH08311480A (ja) * | 1995-05-18 | 1996-11-26 | D H Ee Kodo Seisei Chushutsu Gijutsu Kenkyu Kumiai | 高純度トリアシルグリセロールからなる油脂の製造方法及び高度不飽和脂肪酸含有油脂組成物 |
| JP3391798B2 (ja) | 1995-09-25 | 2003-03-31 | 花王株式会社 | エステル化合物及び潤滑油組成物 |
| US5908631A (en) * | 1997-02-27 | 1999-06-01 | L'oreal S.A. | Monohydric alcohol-free composition for topical use comprising solubilized ethylcellulose |
| US5885616A (en) | 1997-08-18 | 1999-03-23 | Impax Pharmaceuticals, Inc. | Sustained release drug delivery system suitable for oral administration |
| US6278006B1 (en) | 1999-01-19 | 2001-08-21 | Cargill, Incorporated | Transesterified oils |
| WO2000045649A1 (en) * | 1999-02-05 | 2000-08-10 | Baylor University Medical Center | Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid |
| US20030162833A1 (en) | 2001-08-01 | 2003-08-28 | Roe Charles R. | Fatty acid treatment for cardiac patients |
| DE60130083T2 (de) | 2000-10-16 | 2008-05-15 | Nof Corp. | Herstellung von Estern für die Verwendung als Basisschmieröl |
| JP4282289B2 (ja) | 2002-08-29 | 2009-06-17 | 株式会社ジャパンエナジー | 流体軸受用潤滑油及びそれを用いた流体軸受 |
| AU2003261928A1 (en) | 2002-09-05 | 2004-03-29 | The Nisshin Oillio Group, Ltd. | Agents, foods and drinks controlling lipid metabolism |
| US8399515B2 (en) * | 2003-05-20 | 2013-03-19 | Baylor Research Institute | Five and fifteen carbon fatty acids for treating metabolic disorders and as nutritional supplements |
| US20050058673A1 (en) * | 2003-09-09 | 2005-03-17 | 3M Innovative Properties Company | Antimicrobial compositions and methods |
| WO2005120484A1 (ja) | 2004-06-09 | 2005-12-22 | Kurume University | グレリンの生理学的機能のレギュレーター |
| US7141114B2 (en) * | 2004-06-30 | 2006-11-28 | Rec Silicon Inc | Process for producing a crystalline silicon ingot |
| EP1773317A4 (en) | 2004-07-02 | 2012-10-03 | Baylor Res Inst | METHOD OF TREATING OVERLOADING DISEASE DUE TO ACCUMULATION OF GLYCOGENES OR POLYSACCHARIDES |
| WO2006099325A2 (en) | 2005-03-10 | 2006-09-21 | 3M Innovative Properties Company | Methods of treating ear infections |
| BRPI0608691A2 (pt) * | 2005-03-10 | 2010-12-07 | 3M Innovative Properties Company | composição antimicrobiana, e, métodos para matar ou inativar microorganismos em tecido da mucosa de um mamìfero, para tratar uma lesão ou ferimento infectado, para descolonização de microorganismos, para proporcionar eficácia antimicrobiana residual sobre uma superfìcie e para tratar uma condição |
| FR2894822B1 (fr) | 2005-12-20 | 2011-11-18 | Pf Medicament | Composition pharmaceutique contenant des acides gras omega-3 |
| EP1991208A2 (en) | 2006-02-10 | 2008-11-19 | SportsCom Danmark ApS | Coated tablets, their methods of preparation, and related uses |
| JP5099808B2 (ja) | 2006-05-29 | 2012-12-19 | 独立行政法人農業・食品産業技術総合研究機構 | 脂質代謝改善用組成物 |
| CN101730475A (zh) | 2007-05-08 | 2010-06-09 | 帝斯曼知识产权资产管理有限公司 | 体重维持和机体组成 |
| JP5296366B2 (ja) * | 2007-10-29 | 2013-09-25 | 日清オイリオグループ株式会社 | 医薬品用持久力向上剤および持久力向上用医薬品 |
| CA2719246A1 (en) | 2008-03-26 | 2009-10-01 | Taro Pharmaceuticals North America, Inc. | Stabilizing lipid compositions for oral pharmaceutical agents |
| WO2009134460A1 (en) | 2008-04-29 | 2009-11-05 | Hyperion Therapeutics | Methods of treatment using ammonia-scavenging drugs |
| ES2695534T3 (es) | 2008-08-29 | 2019-01-08 | Horizon Therapeutics Llc | Métodos de tratamiento usando fármacos de captación de amoniaco |
| KR20120129898A (ko) | 2009-12-30 | 2012-11-28 | 베일러 리서치 인스티튜트 | 알츠하이머 질환 및 노화 뇌를 위한 보충대사 치료요법 |
| JP2013528648A (ja) * | 2010-06-14 | 2013-07-11 | ベイラー リサーチ インスティテュート | 成人ポリグルコサン小体病（ａｐｂｄ）を処置するためのトリヘプタノイン食 |
| US8932646B2 (en) | 2010-06-18 | 2015-01-13 | Bausch & Lomb Incorporated | Peroxide contact lens care solution |
| CN101919453B (zh) * | 2010-08-16 | 2013-04-10 | 苏州市佳禾食品工业有限公司 | 中碳链脂肪酸粉末油脂及其制备方法 |
| JP5820256B2 (ja) | 2011-02-10 | 2015-11-24 | 株式会社ファンケル | 自己乳化製剤 |
| WO2013012699A2 (en) | 2011-07-15 | 2013-01-24 | 3M Innovative Properties Company | Polyurethane based coating compositions |
| EP3263102A1 (en) | 2011-09-30 | 2018-01-03 | Horizon Therapeutics, LLC | Methods of therapeutic monitoring of nitrogen scavenging drugs |
| JP6080269B2 (ja) | 2012-02-15 | 2017-02-15 | 日清オイリオグループ株式会社 | 飼料用組成物、飼料、及び飼料の製造方法 |
| TWI572352B (zh) * | 2012-03-01 | 2017-03-01 | 波麥堤克藥學Ｓｍｔ有限公司 | 用於製備具中鏈長度之脂肪酸的三酸甘油酯之方法 |
| EP2838522B1 (en) * | 2012-04-16 | 2024-02-21 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Phenylbutyrate for the treatment of medium-chain acyl-coa dehydrogenase deficiency |
| CA2894456C (en) | 2012-12-13 | 2022-06-28 | Baylor Research Institute | Triheptanoin for the treatment of glucose transporter 1 deficiency |
| AU2014296415B2 (en) | 2013-07-31 | 2019-11-21 | The Children's Hospital Of Philadelphia | Compositions and methods for the treatment of fatty acid metabolism disorders |
| CN105764497A (zh) | 2013-11-14 | 2016-07-13 | 奥特吉尼克斯制药公司 | 三酸甘油酯的固体组合物及其用途 |
| WO2020014428A1 (en) | 2018-07-11 | 2020-01-16 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Method of treating fatty acid oxidation disorders using omega3/omega6 unsaturated or branched chain fatty acids |
-
2014
- 2014-11-14 CN CN201480064471.7A patent/CN105764497A/zh active Pending
- 2014-11-14 JP JP2016529444A patent/JP2017501972A/ja active Pending
- 2014-11-14 PE PE2016000621A patent/PE20161024A1/es not_active Application Discontinuation
- 2014-11-14 KR KR1020167013964A patent/KR102291310B1/ko active Active
- 2014-11-14 WO PCT/US2014/065693 patent/WO2015073816A1/en not_active Ceased
- 2014-11-14 CA CA2929688A patent/CA2929688C/en active Active
- 2014-11-14 ES ES14861440T patent/ES2833294T3/es active Active
- 2014-11-14 AR ARP140104294A patent/AR099353A1/es not_active Application Discontinuation
- 2014-11-14 AU AU2014348470A patent/AU2014348470B2/en active Active
- 2014-11-14 EP EP20196269.3A patent/EP3782610A1/en active Pending
- 2014-11-14 MX MX2016006329A patent/MX383005B/es unknown
- 2014-11-14 EP EP14861440.7A patent/EP3068383B1/en active Active
- 2014-11-14 CN CN202110316004.0A patent/CN113181158A/zh active Pending
- 2014-11-14 MY MYPI2016000861A patent/MY177028A/en unknown
- 2014-11-14 US US14/419,601 patent/US20160243071A1/en not_active Abandoned
- 2014-11-14 CA CA3197154A patent/CA3197154A1/en active Pending
- 2014-11-14 TW TW103139665A patent/TWI640327B/zh active
- 2014-11-14 RU RU2016123169A patent/RU2016123169A/ru unknown
-
2016
- 2016-05-03 PH PH12016500821A patent/PH12016500821A1/en unknown
- 2016-05-10 IL IL245588A patent/IL245588B/en unknown
- 2016-05-11 CL CL2016001130A patent/CL2016001130A1/es unknown
- 2016-05-13 MX MX2021001790A patent/MX2021001790A/es unknown
-
2019
- 2019-06-19 US US16/445,557 patent/US20200069631A1/en not_active Abandoned
-
2020
- 2020-03-11 JP JP2020041943A patent/JP2020111585A/ja active Pending
-
2022
- 2022-05-16 JP JP2022080251A patent/JP2022107017A/ja active Pending
-
2023
- 2023-02-10 US US18/167,551 patent/US12551461B2/en active Active
- 2023-10-03 AR ARP230102641A patent/AR130666A2/es unknown
-
2024
- 2024-07-02 JP JP2024106876A patent/JP2024129109A/ja active Pending
- 2024-12-26 US US19/002,257 patent/US20250120936A1/en active Pending
- 2024-12-26 US US19/002,233 patent/US20250120935A1/en active Pending
- 2024-12-26 US US19/002,217 patent/US20250120934A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR121135A2 (es) | Solución no acuosa de regulador(es) de crecimiento vegetal y solvente(s) orgánicos polar(es) y/o semi-polar(es) | |
| CU20210009A7 (es) | Compuestos derivados de tieno pirrolo-triazina acetamida sustituida como inhibidores de la actividad inflamatoria de la proteína receptora tipo nod 3 (nlrp3) | |
| DOP2018000268A (es) | Derivados de carbonucleósidos sustituidos útiles como agentes antineoplásicos | |
| CL2017002155A1 (es) | Derivados de nucleósidos sustituidos útiles como agentes antineoplásicos | |
| CO2018002063A2 (es) | Análogos novedosos de nucleósidos sustituidos en el anillo aromático bicíclico 6-6 para su uso como inhibidores de prmt5 | |
| AR089774A1 (es) | Derivados de indolizina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| CU20140081A7 (es) | Nuevos derivados de pirrol, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| DOP2015000270A (es) | Potenciador de inhibidores del homólogo de zeste | |
| CR20160119A (es) | Nuevos compuestos y sus composiciones farmacéuticas para el tratamiento de la fibrosis quística | |
| CO6620055A2 (es) | Ciertas amino-pirimidinas, composiciones de las mismas y métodos para el uso de los mismos | |
| AR099353A1 (es) | Composiciones de triglicéridos y usos de las mismas | |
| CU20140095A7 (es) | Nuevos derivados fosfatos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| NI201200191A (es) | Derivados de indolizina, su procedimiento de preparación y su aplicación en terapéutica | |
| ECSP13012519A (es) | Compuestos sustituidos de benzamida | |
| CR20140195A (es) | Compuestos de 1,2,5-oxadiazol sustituido y su uso como herbicidas | |
| CU24078B1 (es) | Tres compuestos de sulfonamidas anilladas | |
| CL2017000863A1 (es) | Composición de activo de suavizante de tejidos | |
| CR20140217A (es) | Compuestos de 1,2,5-oxadiazol sustituido y su uso como herbicidas ii | |
| CO7111275A2 (es) | Inhibidores de dgat1 de éter cíclico de cabeza de puente | |
| AR094790A1 (es) | Derivados sustituidos del ácido bisfenil butanóico fosfónico como inhibidores de la nep | |
| UY33415A (es) | Composiciones de alcoxicarboxamidas microbiocidas y fungicidas y su preparacion | |
| AR096472A1 (es) | Compuestos y composiciones antimicrobianos | |
| AR090376A1 (es) | Compuestos herbicidas | |
| AR101077A1 (es) | Triterpenoides con actividad inhibidora de la maduración de hiv | |
| CU20160148A7 (es) | Compuestos de azol sustituidos con amida como inhibidores de tnks1 y/o tnks2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |